期刊
ANALYTICAL CHEMISTRY
卷 94, 期 32, 页码 11175-11184出版社
AMER CHEMICAL SOC
DOI: 10.1021/acs.analchem.2c01433
关键词
-
资金
- NSF [CHE-2203602]
- Robert A. Welch Foundation [F-1155]
- UT System
With the rapid development of new biotherapeutics, it is crucial to ensure consistent quality and understand degradation pathways. This study presents a comprehensive mass spectrometry approach to analyze the sequences and structures of selenoproteins, as well as discover unknown by-products.
With the rapid acceleration in the design and development of new biotherapeutics, ensuring consistent quality and understanding degradation pathways remain paramount, requiring an array of analytical methods including mass spectrometry. The incorporation of non-canonical amino acids, such as for synthetic selenoproteins, creates additional challenges. A comprehensive strategy to characterize selenoproteins should serve dual purposes of providing sequence confirmation and mapping of selenocysteine bridge locations and the identification of unanticipated side products. In the present study, a combined approach exploiting the benefits of both top-down and bottom-up mass spectrometry was developed. Both electron-transfer/higher-energy collision dissociation and 213 urn ultraviolet photodissociation were utilized to provide complementary information, allowing high quality characterization, localization of diselenide bridges for complex proteins, and the identification of previously unreported selenoprotein dieters.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据